HRD Tests for Ovarian cancER

PHASE2RecruitingINTERVENTIONAL
Enrollment

88

Participants

Timeline

Start Date

February 15, 2024

Primary Completion Date

June 30, 2031

Study Completion Date

June 30, 2031

Conditions
Ovarian Cancer
Interventions
GENETIC

tests to determine HRD status

"Test Giscar AND test myChoice will be performed.~If one or two tests identifies a HRD status :~a PARP inhibitor treatment may be initiated according to current recommendations"

Trial Locations (4)

Unknown

NOT_YET_RECRUITING

Chu Amiens, Amiens

RECRUITING

Centre Francois Baclesse, Caen

RECRUITING

Centre Oscar Lambret, Lille

RECRUITING

Centre Henri Becquerel, Rouen

All Listed Sponsors
lead

Centre Francois Baclesse

OTHER